Dermatology · Winston Salem, NC
NPI
1720063175
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4618 Country Club Rd
Winston Salem, NC, 27104
Phone (336) 716-3926
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
717 services
Medicare patients, 2024
319
Average age 73
Drug cost, 2024
$4.5M
1,147 prescriptions
Company payments, 2025
$402K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven R Feldman was code 99213 (office e&m - established), 190 times for 170 patients. In total Steven R Feldman billed 717 services in 22 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 190 | 170 | $44.27 | $8,412 |
| 17003 Destruction Skin Lesion | Office | 140 | 38 | $1.34 | $187 |
| 99214 Office E&M - Established | Office | 111 | 91 | $61.67 | $6,845 |
| 17000 Destruction Skin Lesion | Office | 59 | 56 | $31.45 | $1,855 |
| 17110 Destruction Skin Lesion | Office | 49 | 46 | $45.33 | $2,221 |
| 11102 Skin Biopsy | Office | 49 | 46 | $25.87 | $1,268 |
| 99203 Office E&M - New | Office | 34 | 34 | $51.58 | $1,754 |
| 99202 Office E&M - New | Office | 29 | 29 | $27.39 | $794 |
| 11103 Skin Biopsy | Office | 24 | 12 | $17.02 | $409 |
By year: 2022 $24K for 681 services; 2023 $23K for 579 services; 2024 $25K for 717 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steven R Feldman prescribed most often to Medicare patients was Clobetasol Propionate, with 155 prescriptions and refills. In total Steven R Feldman wrote 1,147 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 155 | 179 | 70 | $9,809 |
| Triamcinolone Acetonide Generic | 112 | 145 | 66 | $1,788 |
| Skyrizi Pen Risankizumab-Rzaa | 89 | 230 | 30 | $1.8M |
| Dupixent Pen Dupilumab | 54 | 54 | 13 | $200K |
| Doxycycline Hyclate Generic | 43 | 55 | 21 | $1,346 |
| Ketoconazole Generic | 38 | 46 | 14 | $665 |
| Humira(Cf) Pen Adalimumab | 35 | 35 | Under 11 | $295K |
| Cosentyx Sensoready (2 Pens) Secukinumab | 35 | 35 | Under 11 | $253K |
| Otezla Apremilast | 33 | 33 | Under 11 | $158K |
| Tremfya Guselkumab | 33 | 60 | 12 | $436K |
| Methotrexate Methotrexate Sodium | 33 | 63 | 12 | $725 |
| Tacrolimus Generic | 31 | 34 | Under 11 | $3,272 |
| Terbinafine Hcl Generic | 30 | 66 | 14 | $413 |
| Stelara Ustekinumab | 27 | 70 | Under 11 | $522K |
| Calcipotriene Generic | 26 | 26 | Under 11 | $3,192 |
Brand drugs: 455 claims; generic drugs: 692 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven R Feldman $402K ($402K in general payments such as food, travel and fees) from 21 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $153K.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 113 | $153K |
| Janssen Biotech, Inc. JNJ | 52 | $104K |
| Lilly USA, LLC LLY | 35 | $55K |
| Abbvie Inc. ABBV | 14 | $27K |
| Amgen Inc. AMGN | 19 | $22K |
| E.R. Squibb & Sons, L.L.C. BMY | 16 | $14K |
| LEO Pharma AS | 1 | $7,240 |
| LEO Pharma Inc. | 3 | $4,690 |
| Janssen Scientific Affairs, LLC JNJ | 3 | $4,662 |
| Merck Sharp & Dohme LLC MRK | 1 | $3,840 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.